Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Inspyr Therapeutics, Inc. | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - Inspyr Therapeutics, Inc. | v404696_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Inspyr Therapeutics, Inc. | v404696_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Inspyr Therapeutics, Inc. | v404696_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Inspyr Therapeutics, Inc. | v404696_ex31-2.htm |
| 10-K - 10-K - Inspyr Therapeutics, Inc. | v404696_10k.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (SEC File No. 333-192553) of Genspera, Inc. of our report which includes an explanatory paragraph as to the Company’s ability to continue as a going concern dated March 20, 2015 relating to our audit of the financial statements which appear in this Annual Report on Form 10-K of Genspera, Inc. for the years ended December 31, 2014 and 2013.
| /s/ Liggett, Vogt & Webb, P.A. | ||
| March 23, 2015 | ||
| New York, New York |